Cargando…

1538. Is there value in performing yearly screening for latent tuberculosis infection by interferon-gamma release assay among patients living with HIV in non-endemic settings?

BACKGROUND: People with HIV (PWH) are at increased risk of reactivation of tuberculosis (TB) from latent tuberculosis infection (LTBI). Current guidelines recommend all PWH be initially screened for LTBI with either interferon-gamma release assays (IGRA) or tuberculin skin testing (TST). Also, repea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Palacios, Carlo Foppiano, Achhra, Amit, Barakat, Lydia A, Virata, Michael, Hao, Richie, Baxter, John D, Malinis, Maricar F
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678242/ http://dx.doi.org/10.1093/ofid/ofad500.1373

Ejemplares similares

622. Development of Interferon-Gamma Release Assays for Diagnosing Latent Talaromycosis
por: Xu, Helen, et al.
Publicado: (2023)

Interferon-gamma release assay for the diagnosis of latent tuberculosis infection: A latent-class analysis
por: Doan, Tan N., et al.
Publicado: (2017)

535. Evaluation of the BioFire Blood Culture Identification (BCID2) panel for transplant recipients with a bloodstream infection
por: Palacios, Carlo Foppiano, et al.
Publicado: (2022)

Risk Stratification of Latent Tuberculosis Defined by Combined Interferon Gamma Release Assays
por: Corbière, Véronique, et al.
Publicado: (2012)

Interferon gamma release assays for detection of latent Mycobacterium tuberculosis in older Hispanic people
por: Scordo, Julia M., et al.
Publicado: (2021)

Validation and Clinical Application of Interferon-Gamma Release Assay for Diagnosis of Latent Tuberculosis Infection in Children
por: Benachinmardi, Kirtilaxmi K, et al.
Publicado: (2019)

Efficacy of an 8-week course of sofosbuvir and ledipasvir for the treatment of HCV infection in selected HIV-infected patients
por: Ogbuagu, Onyema, et al.
Publicado: (2018)

Serial Interferon-gamma Release Assays for the Diagnosis of Latent Tuberculosis Infection in Patients Treated with Immunosuppressive Agents
por: Kim, Kyeong-Hee, et al.
Publicado: (2011)

Diagnosis of latent tuberculosis infection among HIV discordant partners using interferon gamma release assays
por: Talati, Naasha J, et al.
Publicado: (2011)

Tuberculin Skin Testing and Treatment Modulates Interferon-Gamma Release Assay Results for Latent Tuberculosis in Migrants
por: O'Shea, Matthew K., et al.
Publicado: (2014)

Chest roentgenography is complementary to interferon-gamma release assay in latent tuberculosis infection screening of rheumatic patients
por: Wang, Ping-Huai, et al.
Publicado: (2020)

Interferon-gamma release assays for diagnosis of latent TB infection in chronic kidney diseases and dialysis patients
por: Hayuk, Pattorn, et al.
Publicado: (2022)

Predictors for False-Negative Interferon-Gamma Release Assay Results in Hemodialysis Patients with Latent Tuberculosis Infection
por: Park, Heechul, et al.
Publicado: (2022)

1478. Evaluation Of Anal Cancer Screening Program in men who have sex with men (MSM) persons with HIV (PWH) At Two academic center HIV Clinics 2018-2022
por: Achhra, Amit, et al.
Publicado: (2023)

Interferon-Gamma Release Assays versus Tuberculin Skin Testing for the Diagnosis of Latent Tuberculosis Infection: An Overview of the Evidence
por: Trajman, A., et al.
Publicado: (2013)

The Usefulness of the Tuberculosis Skin Test and the Interferon-gamma Release Assay in the Diagnosis of Latent Tuberculosis Infection in South Korea
por: Jang, Ju Young, et al.
Publicado: (2014)

Comparison of interferon gamma release assay & tuberculin skin tests for diagnosis of latent tuberculosis in patients on maintenance haemodialysis
por: Agarwal, Sanjay K., et al.
Publicado: (2015)

Circulating granulysin levels in healthcare workers and latent tuberculosis infection estimated using interferon-gamma release assays
por: Thuong, Pham Huu, et al.
Publicado: (2016)

Evaluation of role of interferon gamma release assays in the diagnosis of latent tuberculosis in human immunodeficiency virus-infected patients
por: Singh, Rajender, et al.
Publicado: (2021)

Utility of the Interferon-Gamma Release Assay for Latent Tuberculosis Infection Screening among Indian Health-Care Workers
por: Girish, Sunita, et al.
Publicado: (2021)

Evaluation of a New Chemiluminescent Immunoassay-Based Interferon-Gamma Release Assay for Detection of Latent Tuberculosis Infection
por: Kim, Keun Ju, et al.
Publicado: (2023)

Basic and clinical immunology- 3019. Gamma interferon release assay for diagnosis of latent tuberculosis – comparison with TB skin test
por: Kumar, Prem, et al.
Publicado: (2013)

1476 Screening for Latent Tuberculosis Infection in Internationally Adopted Children in the era of Interferon-Gamma Release Assay (IGRA) Testing
por: Dhar, Cherie Priya, et al.
Publicado: (2014)

Concordance between tuberculin skin test and interferon-gamma release assay for latent tuberculosis screening in inflammatory bowel disease
por: Alrajhi, Saad, et al.
Publicado: (2020)

Is the New Interferon-Gamma Releasing Assay Beneficial for the Diagnosis of Latent and Active Mycobacterium tuberculosis Infections in Tertiary Care Setting?
por: Jung, Jaewan, et al.
Publicado: (2021)

Fewer losses in the cascade of care for latent tuberculosis with solo interferon-gamma release assay screening compared to sequential screening
por: Lim, R. K., et al.
Publicado: (2021)

Interferon-gamma release assay versus tuberculin skin test for latent tuberculosis infection among HIV patients in Brazil
por: Kussen, Gislene Maria Botão, et al.
Publicado: (2015)

Indeterminate results of interferon gamma release assays in the screening of latent tuberculosis infection: a systematic review and meta-analysis
por: Zhou, Guozhong, et al.
Publicado: (2023)

The Use of Interferon Gamma Release Assays in the Diagnosis of Active Tuberculosis
por: Vesenbeckh, Silvan M., et al.
Publicado: (2012)

Interferon-Gamma Release Assay Performance in Pulmonary and Extrapulmonary Tuberculosis
por: Feng, Yun, et al.
Publicado: (2012)

1760. Interferon Gamma Release Assay for Diagnosis of Lyme disease
por: Hefter, Yosefa, et al.
Publicado: (2018)

Interferon-Gamma Release Assay for the Diagnosis of Latent TB Infection – Analysis of Discordant Results, when Compared to the Tuberculin Skin Test
por: Nienhaus, Albert, et al.
Publicado: (2008)

Interferon Gamma Release Assays for the Diagnosis of Latent TB Infection in HIV-Infected Individuals in a Low TB Burden Country
por: Ní Cheallaigh, Clíona, et al.
Publicado: (2013)

Serial interferon-gamma release assays for latent tuberculosis in dialysis patients with end stage renal disease in a Korean population
por: Lee, Seung Heon, et al.
Publicado: (2015)

Risk Factors for Indeterminate Outcome on Interferon Gamma Release Assay in Non-US-Born Persons Screened for Latent Tuberculosis Infection
por: Sharninghausen, Jody C, et al.
Publicado: (2018)

Factors associated with non-initiation of latent tuberculosis treatment among healthcare workers with a positive interferon-gamma releasing assay
por: Lee, Hyun, et al.
Publicado: (2019)

1377. Use of Interferon-Gamma Release Assays (IGRAs) Reduced Latent Tuberculosis Infection (LTBI) Diagnosis in Refugee and Immigrant Children
por: Kushner, Lauren E, et al.
Publicado: (2019)

Comparison of Interferon Gamma Release Assay and Tuberculin Skin Test for Diagnosis of Latent Tuberculosis in Psoriasis Patients Planned for Systemic Therapy
por: Neema, Shekhar, et al.
Publicado: (2022)

Screening travellers to high-endemic countries for infection with Mycobacterium tuberculosis using interferon gamma release assay; a prospective study
por: Elfrink, Floor, et al.
Publicado: (2014)

Los Andakí, 1538-1947 : historia de la aculturación de una tribu selvática
por: Friede, Juan
Publicado: (1953)

Cannot write session to /tmp/vufind_sessions/sess_qvesd3uc264sfd0acpmj8np0ut